Colby Pharmaceutical Company

5941 Optical Court
San Jose, CA 95138 USA
Click for website

Research Sector Pharmaceutical

Summary Description Develops biologic and small molecule drugs to treat or cure cancer and neuropathic pain.

Management David Zarling PhD MBA, Chief Executive Officer

Click here for Financial Data
Keywords: signal transduction modulator drugs, cancer, pain, prostate cancer


Updated: Jan. 06, 2016


Colby Pharmaceuticals is a biotech company that has developed an innovative therapeutic platform of drug candidates that modulate the metabolic pathways, which underlie disease progression, specifical......view more

Products / Services

CPC-100, CPC-200......view more

Technology / Differentiation

ILNI inoculation directly into normal lymph nodes, using ultrasound image guided syringes of viral or cancer vaccine antigens, produces much more potent therapeutic T-cell responses compared to immuni...view more

Revenue / Funding

Colby has been primarily financed by non-dilutive grants and contracts. In 2011, Colby also sold to Adamis Pharmaceuticals Corp. its rights for two preclinical assets and one clinical asset which wer...view more


In a Phase 1 human melanoma study of MKC1106-MT, the most advanced ILNI regimen from this program, clearly met the primary endpoints as repeat intra-lymph nodal injections for administration of the th...view more